{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T18:39:09Z","timestamp":1786819149300,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["-00120-14"],"award-info":[{"award-number":["-00120-14"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["-00928-11"],"award-info":[{"award-number":["-00928-11"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002425","name":"Governo Brasil","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["471725\/2013-7"],"award-info":[{"award-number":["471725\/2013-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.clnesp.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T17:45:28Z","timestamp":1558719928000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Increased resting metabolism in neurofibromatosis type 1"],"prefix":"10.1016","volume":"32","author":[{"given":"Marcio Leandro Ribeiro de","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Kristine","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Oswaldo Carneiro","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene Larissa de Souza","family":"Vilela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana Maria","family":"Kakehasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Stangherlin","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Ferreira de","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilton Alves de","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2019.05.006_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/0004-282X20130241","article-title":"Neurofibromatoses: part 1 \u2013 diagnosis and differential diagnosis","volume":"72","author":"Rodrigues","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.clnesp.2019.05.006_bib2","first-page":"172","article-title":"National institutes of health consensus development conference statement: neurofibromatosis. Bethesda, Md., USA, July 13\u201315, 1987","volume":"1","year":"1988","journal-title":"Neurofibromatosis"},{"key":"10.1016\/j.clnesp.2019.05.006_bib3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.nut.2014.12.021","article-title":"Nutrient intake in neurofibromatosis type 1: a cross-sectional study","volume":"31","author":"Souza","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.clnesp.2019.05.006_bib4","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1590\/S0104-42302009000400012","article-title":"Neurofibromatose Tipo 1: mais comum e mais grave do que se imagina","volume":"55","author":"Souza","year":"2009","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.clnesp.2019.05.006_bib5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1590\/1806-9282.62.09.831","article-title":"Body composition in adults with neurofibromatosis type 1","volume":"62","author":"Souza","year":"2016","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.clnesp.2019.05.006_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.20945\/2359-3997000000007","article-title":"Increased insulin sensitivity in individuals with neurofibromatosis type 1","volume":"62","author":"Martins","year":"2018","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.clnesp.2019.05.006_bib7","first-page":"145","article-title":"Case-control study of the muscular compartments and osseous strength in neurofibromatosis type 1 using peripheral quantitative computed tomography","volume":"5","author":"Stevenson","year":"2005","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.clnesp.2019.05.006_bib8","first-page":"15","article-title":"Muscular force is reduced in neurofibromatosis type 1","volume":"9","author":"Souza","year":"2009","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.clnesp.2019.05.006_bib9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/ddx423","article-title":"Dietary intervention rescues myopathy associated with neurofibromatosis type 1","volume":"27","author":"Summers","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clnesp.2019.05.006_bib10","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1590\/S0102-311X2001000400015","article-title":"Historical and methodological aspects of the measurement and prediction of basal metabolic rate: a review","volume":"17","author":"Wahrlich","year":"2001","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.clnesp.2019.05.006_bib11","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1079\/PHN2005800","article-title":"Measurement of energy expenditure","volume":"8","author":"Levine","year":"2005","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.clnesp.2019.05.006_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.clnu.2016.06.010","article-title":"Indirect calorimetry in nutritional therapy. A position paper by the ICALIC study group","volume":"36","author":"Oshima","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2019.05.006_bib13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3945\/ajcn.112.036350","article-title":"Energy balance and its components: implications for body weight regulation","volume":"95","author":"Hall","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2019.05.006_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ejcn.2013.38","article-title":"Measuring energy expenditure in clinical populations: rewards and challenges","volume":"67","author":"Psota","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnesp.2019.05.006_bib15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ajcn\/82.5.941","article-title":"Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine","volume":"82","author":"Johnstone","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2019.05.006_bib16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jada.2006.02.009","article-title":"Best practice methods to apply to measurement of resting metabolic rate in adults: a systematic review","volume":"106","author":"Compher","year":"2006","journal-title":"J\u00a0Am Diet Assoc"},{"key":"10.1016\/j.clnesp.2019.05.006_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/0115426507022004377","article-title":"Indirect calorimetry: a practical guide for clinicians","volume":"22","author":"Haugen","year":"2007","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnesp.2019.05.006_bib18","series-title":"RMR equipment: instructions manual","author":"COSMED","year":"2014"},{"key":"10.1016\/j.clnesp.2019.05.006_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1949.sp004363","article-title":"New methods for calculating metabolic rate with special reference to protein metabolism","volume":"109","author":"Weir","year":"1949","journal-title":"J\u00a0Physiol Lond"},{"key":"10.1016\/j.clnesp.2019.05.006_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1123\/ijsnem.2013-0228","article-title":"Methodology review: using dual-energy X-ray absorptiometry (DXA) for the assessment of body composition in athletes and active people","volume":"25","author":"Nana","year":"2015","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"10.1016\/j.clnesp.2019.05.006_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2017.06.010","article-title":"Body composition by DXA","volume":"104","author":"Shepherd","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.clnesp.2019.05.006_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.clnesp.2019.05.006_bib23","series-title":"Physical status: the use and interpretation of anthropometry. Geneva","first-page":"452","author":"World Health Organization","year":"1995"},{"key":"10.1016\/j.clnesp.2019.05.006_bib24","series-title":"Waist circumference and waist-hip ratio","author":"World Health Organization","year":"2011"},{"key":"10.1016\/j.clnesp.2019.05.006_bib25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","article-title":"A\u00a0formula to estimate the approximate surface area if height and weight be known","volume":"17","author":"DuBois","year":"1916","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clnesp.2019.05.006_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpeds.2015.11.076","article-title":"Understanding growth failure in Costello Syndrome: increased resting energy expenditure","volume":"170","author":"Leoni","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clnesp.2019.05.006_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.clnesp.2019.05.006_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.33549\/physiolres.932306","article-title":"Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease","volume":"61","author":"Brusik","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.clnesp.2019.05.006_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/09513590.2017.1379492","article-title":"Association between uncoupling protein 2, adiponectin and resting energy expenditure in obese women with normal and low resting energy expenditure","volume":"34","author":"Masoumi","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.clnesp.2019.05.006_bib30","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nm1029","article-title":"Adiponectin acts in the brain to decrease body weight","volume":"10","author":"Qi","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.clnesp.2019.05.006_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cmet.2007.06.003","article-title":"Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake","volume":"6","author":"Kubota","year":"2007","journal-title":"Cell Metabol"},{"key":"10.1016\/j.clnesp.2019.05.006_bib32","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00394-015-1021-z","article-title":"Vitamin D status and insulin sensitivity are novel predictors of resting metabolic rate: a cross-sectional analysis in Australian adults","volume":"55","author":"Calton","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnesp.2019.05.006_bib33","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1172\/JCI99424","article-title":"Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis","volume":"128","author":"Liao","year":"2018","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.clnesp.2019.05.006_bib34","first-page":"6138","article-title":"Effect of different tumor types on resting energy expenditure","volume":"51","author":"Fredrix","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.clnesp.2019.05.006_bib35","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/01635581.2016.1153667","article-title":"Comparison of resting energy expenditure between cancer subjects and healthy controls: a meta-analysis","volume":"68","author":"Nguyen","year":"2016","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.clnesp.2019.05.006_bib36","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/2009.11.FOCUS09221","article-title":"Neurofibromatosis type 1 and tumorigenesis: molecular mechanisms and therapeutic implications","volume":"28","author":"Gottfried","year":"2010","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.clnesp.2019.05.006_bib37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bbabio.2018.05.003","article-title":"RAS signaling in energy metabolism and rare human diseases","volume":"1859","author":"Dard","year":"2018","journal-title":"Biochim Biophys Acta Bioenergy"},{"key":"10.1016\/j.clnesp.2019.05.006_bib38","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/ajmg.a.32301","article-title":"The role of steroid hormones in the NF1 phenotype: focus on pregnancy","volume":"146A","author":"Roth","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.clnesp.2019.05.006_bib39","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4161\/cbt.10.8.12878","article-title":"Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells","volume":"10","author":"Li","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.clnesp.2019.05.006_bib40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/bjd.13966","article-title":"Neurofibromatosis type 1: neurofibromas and sex","volume":"174","author":"Sbidian","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clnesp.2019.05.006_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13023-017-0734-x","article-title":"Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1","volume":"12","author":"Rozza-de-Menezes","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clnesp.2019.05.006_bib42","first-page":"245","article-title":"Resting energy expenditure; assessment methods and applications","volume":"31","author":"Redondo","year":"2015","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.clnesp.2019.05.006_bib43","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/hmg\/ddt515","article-title":"NF1 is a critical regulator of muscle development and metabolism","volume":"23","author":"Sullivan","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.clnesp.2019.05.006_bib44","first-page":"161","article-title":"Skeletal muscle and motor deficits in Neurofibromatosis Type 1","volume":"15","author":"Summers","year":"2015","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.clnesp.2019.05.006_bib45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/mus.23324","article-title":"Peripheral muscle weakness in rasopathies","volume":"46","author":"Stevenson","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clnesp.2019.05.006_bib46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/dmcn.12777","article-title":"Muscle weakness in children with neurofibromatosis type 1","volume":"57","author":"Cornett","year":"2015","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.clnesp.2019.05.006_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.humov.2011.05.004","article-title":"Lower extremity strength and hopping and jumping ground reaction forces in children with Neurofibromatosis Type 1","volume":"31","author":"Johnson","year":"2012","journal-title":"Hum Mov Sci"},{"key":"10.1016\/j.clnesp.2019.05.006_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ajmg.a.35729","article-title":"Exercise capacity impairment in individuals with neurofibromatosis type 1","volume":"161A","author":"Souza","year":"2013","journal-title":"Am J Med Genet A"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457719301354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457719301354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:37:05Z","timestamp":1778881025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457719301354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":48,"alternative-id":["S2405457719301354"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2019.05.006","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased resting metabolism in neurofibromatosis type 1","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}